Pierre-Antoine Gourraud

Assistant Professor, Translational Digital Medicine at School of Medicine Department of Neurology, University of California at San Francisco

Dr. Pierre-Antoine Gourraud, PhD MPH, is assistant professor in residence at the UCSF Department of Neurology. He is a former student of the Ecole Normale Supérieure de Lyon in France. After an M.P.H. received from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. Soon afterward, he obtained a joint appointment at the Toulouse Hospitals and the Toulouse University in the Department of Public Health. He was in charge of consultation service in the Epidemiology unit of the hospital for 2 years. He relocated to the United States to do his postdoctoral research in neuro-immunogenetics of multiple sclerosis at University of California, San Francisco. In 2011, he joined the UCSF faculty. 

Dr. Gourraud has established numerous research collaborations with investigators from all over the world: He developed bioinformatics tools for the study of MHC microsatellites for the dbMHC website at the NCBI, he performed numerous genetic association studies on various diseases (rheumatoid arthritis, multiple sclerosis, and leukemia), and he also conducted population genetics analyses of European populations (HLA and KIR genes). He developed software dedicated to statistical genetics and designed an algorithm to support decision making for the treatment of hematological diseases. In 2006, Dr Gourraud received an undergraduate degree with honors in Philosophy from Toulouse Catholic University which he used to contribute to the study of bioethical issues in genetics under the dual influence of two of his mentors, Doctor Anne Cambon-Thomsen, former member of the French national advisory bioethics committee and Professor Stephen L Hauser member of the Presidential Commission for the Study of Bioethical Issues. In 2008, he founded Methodomics a French company dedicated to statistical analyses and algorithm development in biology. He is also the leader of the MS Bioscreen project at UCSF with the translational digital medicine group of the department of Neurology. More than 80 publications and 1600 citations attest to his achievements thus far and hold promise for future basic science and innovative applications.